How TruSight Oncology 500 v2 is helping advance cancer research at the Catalan Institute of Oncology
Líder mundial en genómica, Illumina ofrece soluciones integrales de secuenciación de nueva generación en los ámbitos clínicos, de investigación y de aplicaciones.
Learn how researchers at the Catalan Institute of Oncology are using TruSight Oncology 500 v2 to streamline their workflow and accelerate their research. In this video, scientists from the institute talk about the improved assay and share how faster results help drive discovery.
Learn more about TruSight Oncology 500 v2: https://www.illumina.com/products/by-type/clinical-research-products/trusight-oncology-500.html
© 2025 Illumina, Inc. All rights reserved. M-GL-03407
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
Click here to view the full press release and learn more about the enhanced assay: ‘Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling’